{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:46:47Z","timestamp":1785743207879,"version":"3.56.0"},"reference-count":0,"publisher":"American Association for Cancer Research (AACR)","issue":"8","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Phase I trial findings indicate that two different personalized vaccine strategies, DNA-based GNOS-PV01 and peptide-based NeoVax, may be promising strategies for patients with glioblastoma. Notably, the former is effective against MGMT-unmethylated glioblastoma, a subtype for which the prognosis is particularly poor.<\/jats:p>","DOI":"10.1158\/2159-8290.cd-nw2026-0075","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:16:21Z","timestamp":1783070181000},"page":"OF1-OF1","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNA, Peptide Vaccines Advance Against GBM"],"prefix":"10.1158","volume":"16","member":"1086","published-online":{"date-parts":[[2026,7,3]]},"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/doi\/10.1158\/2159-8290.CD-NW2026-0075\/786385\/DNA-Peptide-Vaccines-Advance-Against-GBMDNA","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/8\/OF1\/787099\/DNA-Peptide-Vaccines-Advance-Against-GBMDNA","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/8\/OF1\/787099\/DNA-Peptide-Vaccines-Advance-Against-GBMDNA","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:15:01Z","timestamp":1785741301000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/8\/OF1\/787099\/DNA-Peptide-Vaccines-Advance-Against-GBMDNA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":0,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,3]]},"published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-nw2026-0075","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}